Michelle Batchelor, Senior Manager, Global Program, NASTAD
ALDP Master Trainers and Participants
This month, fourteen District AIDS Coordinators (DACs) and Assistant DACs (ADACs) gathered in Gaborone, Botswana to complete week one of the Applied Leadership Development Program (ALDP) for District HIV and AIDS Coordination Training. DACs and ADACs form the backbone of the district-level HIV response in Botswana, where an estimated 340,000 people are living with HIV. The training was hosted by the Ministry of Local Government & Rural Development (MLG&RD), with support and mentoring provided by NASTAD. Continue reading
By JoAnne Keatley, MSW, Director and Co-Principal Investigator, Center of Excellence for Transgender Health at the University of California San Francisco
JoAnne Keatley, MSW, Director and Co-Principal Investigator, Center of Excellence for Transgender Health at the University of California San Francisco
November has been designated as the National Transgender Awareness Month in order to raise awareness of issues that affect the transgender (trans) community. November 20th is the National Transgender Remembrance Day, an opportunity for the trans community and its allies to stand up against the lack of legal and workplace protection from discrimination and the transphobic violence that threatens daily life. For example, trans youth are harassed and bullied in schools or worse. In Oakland, my own backyard, a 16 year old was set on fire on a municipal bus traveling home from school merely for being their authentic self, because they were assigned a male sex at birth and had dared to wear a skirt and use gender neutral pronouns. This is terrible, heart breaking, and tragic.
By Anna Carroll, Associate, Global Program, NASTAD
NASTAD Haiti staff celebrate NASTAD’s 10th Anniversary Commemoration at our office in Port-au-Prince.
In 2003, a small cohort of NASTAD technical assistance providers visited Port-au-Prince, Haiti to explore the possibility of providing support to the Haiti Ministry of Health (MoH) as it developed its HIV surveillance system. Over the following years, NASTAD partnered with the MoH to design, pilot, and implement one of the few, high-functioning case surveillance systems in the developing world. Today, after ten years of successful collaboration, NASTAD Haiti has an office in Port-au-Prince staffed by 10 local public health practitioners, and has expanded its work to support not only HIV case based surveillance but also enhanced perinatal surveillance of HIV-positive pregnant women and their HIV-exposed babies, and surveillance of HIV/TB co-infection.
By Ronald Valdiserri, M.D., M.P.H., Deputy Assistant Secretary for Health, Infectious Diseases, and Director, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
Cross-posted from AIDS.gov
Drs. Ron Valdiserri, Ellie McCance-Katz, and John Ward dicussing federal viral hepatitis initiatives with Viral Hepatitis Prevention Coordinators from across the country.
Last week I had the opportunity to discuss the federal response to viral hepatitis with some of our key allies in the states: the CDC-funded Adult Viral Hepatitis Prevention Coordinators who had assembled in Washington, DC for the third National Hepatitis Technical Assistance meeting organized and hosted by the National Alliance of State and Territorial AIDS Directors (NASTAD). Continue reading
FOR IMMEDIATE RELEASE
Contact: Murray Penner
October 28, 2013, Washington, DC – The ADAP Crisis Task Force (Task Force) announced today that it has reached agreement with Bristol-Myers Squibb (BMS) and Boehringer Ingelheim (BI) to extend voluntary discounts/rebates and price freezes to all state AIDS Drug Assistance Programs (ADAPs). The continuation of existing agreements beyond 2013 will provide stability to ADAPs as they continue to navigate the uncharted terrain of a reformed health system as a result of implementation of the Affordable Care Act (ACA) and continued fiscal challenges at both the state and federal level.
The Task Force, convened by the National Alliance of State and Territorial AIDS Directors (NASTAD), previously secured continuation through 2014 of existing agreements for voluntary discounts and rebates from AbbVie, Gilead Sciences, Janssen Therapeutics, Merck and ViiV Healthcare. Many of these agreements also provide continued price freezes for ADAPs for varying lengths of time into 2014 and 2015. Continue reading